Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors

Cancer Genomics and Proteomics

Volumn 4, Issue 5, 2007, Pages 359-367

  Biermann, Katharina ^a,e   Heukamp, Lukas Carl ^a   Steger, Klaus ^b   Zhou, Hui ^a   Franke, Folker Ernst ^b   Sonnack, Violetta ^b   Brehm, Ralph ^b   Berg, Johannes ^c   Bastian, Patrick Jan ^a   Müller, Stefan Cajetan ^a   Wang Eckert, Lihua ^d   Buettner, Reinhard ^a  

^a UNIVERSITY OF BONN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Life and Brain Center   (Germany)

^e UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cancer; Embryonal carcinoma; Germ; Seminoma; Testicular

Indexed keywords

CD30 ANTIGEN; COMPLEMENTARY DNA; CYTOKERATIN 18; CYTOKERATIN 8; HEMOPEXIN; KERATIN; MELANOMA ANTIGEN 4; MELANOMA ANTIGEN, FAMILY A, 4 PROTEIN; PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA; PROTEIN DERIVATIVE; SPERM ASSOCIATED ANTIGEN 1; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; DNA MICROARRAY; EMBRYONAL CARCINOMA; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC DIFFERENCE; GENETIC TRANSCRIPTION; GENOME; GERM CELL; GERM CELL TUMOR; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR WEIGHT; PATHOGENESIS; PROTEIN EXPRESSION; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINOMA; SPERMATOGENESIS; TESTIS;

EID: 35948958985     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. McKiernan JM, Goluboff ET, Liberson GL, Golden R et al: Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol 162: 361-363, 1999.
2. Adami HO, Bergstrom R, Mohner M, Zatonski W et al: Testicular cancer in nine northern European countries. J Cancer 59: 33-38, 1994.
3. Skakkebaek NE, Holm M, Hoei-Hansen C, Jorgensen N et al: Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. Apmis 111: 1-9; discussion 9-11, 2003.
4. Skakkebaek NE: Possible carcinoma-in-situ of the testis. Lancet 2: 516-517, 1972.
5. Skakkebaek NE: Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology 2: 157-170, 1978.
6. Oosterhuis JW and Looijenga LH: Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5: 210-222, 2005.
7. Looijenga LH and Oosterhuis JW: Pathogenesis of testicular germ cell tumours. Rev Reprod 4: 90-100, 1999.
8. Almstrup K, Hoei-Hansen CE, Wirkner U, Blake J et al: Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res 64: 4736-4743, 2004.
9. Sperger JM, Chen X, Draper JS, Antosiewicz JE et al: Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci USA 100: 13350-13355, 2003.
10. Pauls K, Schorle H, Jeske W, Brehm R et al: Spatial expression of germ cell markers during maturation of human fetal male gonads: an immunohistochemical study. Hum Reprod 21: 397-404, 2006.
11. Stefano GB, Burrill JD, Labur S, Blake J et al: Regulation of various genes in human leukocytes acutely exposed to morphine: expression microarray analysis. Med Sci Monit 11: 35-42, 2005.
12. Walker SJ, Wang Y, Grant KA, Chan F et al: Long versus short oligonucleotide microarrays for the study of gene expression in nonhuman primates. J Neurosci Methods 152: 179-189, 2006.
13. Almstrup K, Hoei-Hansen CE, Nielsen JE, Wirkner U et al: Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours. Br J Cancer 92: 1934-1941, 2005.
14. Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB et al: Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 66: 820-827, 2006.
15. Hittmair A, Rogatsch H, Hobisch A, Mikuz G et al: CD30 expression in seminoma. Hum Pathol 27: 1166-1171, 1996.
16. Oosterhuis JW and Looijenga LH: Current views on the pathogenesis of testicular germ cell tumours and perspectives for future research: highlights of the 5th Copenhagen Workshop on Carcinoma in situ and Cancer of the Testis. Apmis 111: 280-289, 2003.
17. Mostofi FK and Sesterhenn IA: Pathology of germ cell tumors of testes. Prog Clin Biol Res 203: 1-34, 1985.
18. Grigor KM: A new classification of germ cell tumours of the testis. Eur Urol 23: 93-100; discussion 101-103, 1993.
19. Bobba VS, Mittal BB, Hoover SV and Kepka A: Classical and anaplastic seminoma: difference in survival. Radiology 167: 849-852, 1988.
20. Skotheim RI, Lind GE, Monni O, Nesland JM et al: Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 65: 5588-5598, 2005.
21. Almstrup K, Ottesen AM, Sonne SB, Hoei-Hansen CE et al: Genomic and gene expression signature of the pre-testicular carcinoma in situ. Cell Tissue Res 322: 159-165, 2005.
22. Biermann K, Heukamp LC, Steger K, Zhou H et al: Gene Expression Profiling Identifies New Biological Markers of Neoplastic Germ Cells, Anticancer Res, in press.
23. Zhang C, Kawakami T, Okada Y and Okamoto K: Distinctive epigenetic phenotype of cancer testis antigen genes seminomatous and nonseminomatous testicular germ-cell tumors. Genes Chromosomes Cancer 43: 104-112, 2005.
24. Rodda DJ, Chew JL, Lim LH, Loh YH et al: Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 280: 24731-24737, 2005.
25. Chew JL, Loh YH, Zhang W, Chen X et al: Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 25: 6031-6046, 2005.
26. Kemmer K, Corless CL, Fletcher JA, McGreevey L et al: KIT mutations are common in testicular seminomas. Am J Pathol 164: 305-313, 2004.
27. Juric D, Sale S, Hromas RA, Yu R et al: Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures. Proc Natl Acad Sci USA 102: 17763-17768, 2005.